An Observational Study of Herceptin (Trastuzumab) in Patients With HER2-positive Advanced Gastric Cancer

NCT01220934 · clinicaltrials.gov ↗
COMPLETED
Status
443
Enrollment
INDUSTRY
Sponsor class

Conditions

Sponsor

Hoffmann-La Roche